Lewicki John A. 4
4 · OncoMed Pharmaceuticals Inc · Filed Mar 19, 2018
Insider Transaction Report
Form 4
Lewicki John A.
EVP & Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-03-16+125,000→ 125,000 totalExercise: $2.98Exp: 2028-03-15→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of March 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.